+ |
PRKG1 |
phosphorylation
|
RYR1 |
0.399 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-248918 |
Ser2843 |
KKKTRKIsQSAQTYD |
in vitro |
|
pmid |
sentence |
8380342 |
Automated Edman sequence analysis of the major phosphopeptide obtained from PK-A and PK-G phosphorylation and one phosphopeptide obtained from PK-CaM phosphorylation yielded the sequence KISQTAQTYDPR (residues 28412852) with serine 2843 as phosphorylation site |
|
Publications: |
1 |
Organism: |
In Vitro |
+ |
CAMK2G |
phosphorylation
|
RYR1 |
0.403 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-250704 |
Ser2843 |
KKKTRKIsQSAQTYD |
|
|
pmid |
sentence |
8380342 |
Phosphorylation of serine 2843 in ryanodine receptor-calcium release channel of skeletal muscle by cAMP-, cGMP- and CaM-dependent protein kinase. |
|
Publications: |
1 |
+ |
PRKACA | up-regulates activity
phosphorylation
|
RYR1 |
0.331 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-250078 |
Ser2843 |
KKKTRKIsQSAQTYD |
in vitro |
|
pmid |
sentence |
14532276 |
PKA-mediated hyperphosphorylation of a conserved serine, Ser-2843 in skeletal RyR and Ser-2809 in cardiac RyR, results in an aberrant SR function during heart failure. hyperphosphorylated RyRs are leaky and therefore lead to a reduced SR Ca2+ load and impaired contractile function in heart failure |
|
Publications: |
1 |
Organism: |
In Vitro |